• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬与骨髓微环境:多发性骨髓瘤发病和维持中的保护因子研究进展。

Autophagy and the Bone Marrow Microenvironment: A Review of Protective Factors in the Development and Maintenance of Multiple Myeloma.

机构信息

University of South Carolina School of Medicine Greenville, University of South Carolina, Greenville, SC, United States.

Research and Development Department, Organogenesis, Birmingham, AL, United States.

出版信息

Front Immunol. 2022 May 19;13:889954. doi: 10.3389/fimmu.2022.889954. eCollection 2022.

DOI:10.3389/fimmu.2022.889954
PMID:35663979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9161817/
Abstract

The role of the unfolded protein response (UPR) in plasma cells (PC) and their malignant multiple myeloma (MM) counterparts is a well described area of research. The importance of autophagy in these cells, as well as the interplay between autophagy and the UPR system, has also been well studied. In this review, we will discuss the relationship between these two cellular responses and how they can be utilized in MM to account for the high levels of monoclonal immunoglobulin (Ig) protein synthesis that is characteristic of this disease. Interactions between MM cells and the bone marrow (BM) microenvironment and how MM cells utilize the UPR/autophagy pathway for their survival. These interacting pathways form the foundation for the mechanism of action for bortezomib, a proteasome inhibitor used to modify the progression of MM, and the eventual drug resistance that MM cells develop. One important resistance pathway implicated in MM progression is caspase 10 which attenuates autophagy to maintain its prosurvival function and avoid cell death. We lay a groundwork for future research including 3D models for better disease monitoring and personalized treatment. We also highlight pathways involved in MM cell survival and drug resistance that could be used as new targets for effective treatment.

摘要

未折叠蛋白反应(UPR)在浆细胞(PC)及其恶性多发性骨髓瘤(MM)对应物中的作用是一个研究得很好的领域。自噬在这些细胞中的重要性,以及自噬和 UPR 系统之间的相互作用,也得到了很好的研究。在这篇综述中,我们将讨论这两种细胞反应之间的关系,以及它们如何在 MM 中被利用,以解释这种疾病特有的高水平单克隆免疫球蛋白(Ig)蛋白合成。MM 细胞与骨髓(BM)微环境的相互作用以及 MM 细胞如何利用 UPR/自噬途径来生存。这些相互作用的途径为硼替佐米(一种用于修饰 MM 进展的蛋白酶体抑制剂)的作用机制以及 MM 细胞最终产生的耐药性奠定了基础。在 MM 进展中涉及的一个重要耐药途径是半胱天冬酶 10,它减弱自噬以维持其促生存功能并避免细胞死亡。我们为未来的研究奠定了基础,包括用于更好地疾病监测和个性化治疗的 3D 模型。我们还强调了涉及 MM 细胞存活和耐药性的途径,这些途径可以作为新的有效治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/2499213bf8f5/fimmu-13-889954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/b724bd06ea37/fimmu-13-889954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/93b298ce7f0f/fimmu-13-889954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/2499213bf8f5/fimmu-13-889954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/b724bd06ea37/fimmu-13-889954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/93b298ce7f0f/fimmu-13-889954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68e/9161817/2499213bf8f5/fimmu-13-889954-g003.jpg

相似文献

1
Autophagy and the Bone Marrow Microenvironment: A Review of Protective Factors in the Development and Maintenance of Multiple Myeloma.自噬与骨髓微环境:多发性骨髓瘤发病和维持中的保护因子研究进展。
Front Immunol. 2022 May 19;13:889954. doi: 10.3389/fimmu.2022.889954. eCollection 2022.
2
Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1-Dependent TGFβ1 Activation and Suppressing Immunity in Bone Marrow.成骨细胞中 Runx2 的缺失通过增加 TSP-1 依赖性 TGFβ1 的激活和抑制骨髓中的免疫来促进骨髓瘤对硼替佐米的耐药性。
Mol Cancer Ther. 2022 Feb;21(2):347-358. doi: 10.1158/1535-7163.MCT-21-0310. Epub 2021 Dec 14.
3
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.一种依赖于SQSTM1/p62的可塑性自噬储备维持蛋白质稳态并决定多发性骨髓瘤细胞对蛋白酶体抑制剂的敏感性。
Autophagy. 2015;11(7):1161-78. doi: 10.1080/15548627.2015.1052928.
4
Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.在 3D 替代微环境中对多发性骨髓瘤-骨髓相互作用和药物反应进行建模。
Haematologica. 2018 Apr;103(4):707-716. doi: 10.3324/haematol.2017.167486. Epub 2018 Jan 11.
5
Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.剖析多发性骨髓瘤与骨微环境的关系揭示了新的治疗机会。
J Mol Med (Berl). 2016 Jan;94(1):21-35. doi: 10.1007/s00109-015-1345-4. Epub 2015 Oct 1.
6
Stew in its Own Juice: Protein Homeostasis Machinery Inhibition Reduces Cell Viability in Multiple Myeloma Cell Lines.原汁炖煮:蛋白动态平衡机制抑制降低多发性骨髓瘤细胞系的细胞活力。
Curr Mol Med. 2019;19(2):112-119. doi: 10.2174/1566524019666190305134441.
7
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.骨髓基质细胞诱导多发性骨髓瘤的耐药性。
Int J Mol Sci. 2020 Jan 17;21(2):613. doi: 10.3390/ijms21020613.
8
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.自噬和细胞凋亡:多发性骨髓瘤治疗和耐药性的当前挑战。
Int J Mol Sci. 2022 Dec 30;24(1):644. doi: 10.3390/ijms24010644.
9
Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.老年和青年演员在多发性骨髓瘤骨髓微环境依赖耐药的戏剧中扮演新角色。
Int J Mol Sci. 2018 May 18;19(5):1512. doi: 10.3390/ijms19051512.
10
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.肿瘤相关巨噬细胞通过 STAT3 激活介导骨髓瘤细胞存活。
J Pathol. 2017 Mar;241(4):534-546. doi: 10.1002/path.4860. Epub 2017 Jan 30.

引用本文的文献

1
Activation of Unfolded Protein Response Pathway in Malignancies: Interplay with Extracellular Matrix and Targeting Perspectives.恶性肿瘤中未折叠蛋白反应途径的激活:与细胞外基质的相互作用及靶向治疗前景
Cancers (Basel). 2025 Jun 13;17(12):1972. doi: 10.3390/cancers17121972.
2
Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma Patients.蛋白酶体β5亚基(PSMB5)在硼替佐米耐药的多发性骨髓瘤患者骨髓单个核细胞中的预后价值及其与微管相关蛋白1轻链3Ⅱ型(LC3Ⅱ)和活性氧水平的相关性
Curr Issues Mol Biol. 2025 Jan 6;47(1):32. doi: 10.3390/cimb47010032.
3

本文引用的文献

1
Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction.多发性骨髓瘤细胞龛的结构和超微结构分析以及浆细胞功能障碍的患者特异性模型
Microsc Microanal. 2022 Feb;28(1):254-264. doi: 10.1017/S1431927621013805.
2
Roles of XBP1s in Transcriptional Regulation of Target Genes.XBP1s在靶基因转录调控中的作用。
Biomedicines. 2021 Jul 8;9(7):791. doi: 10.3390/biomedicines9070791.
3
Oxygen-independent disulfide bond formation in VEGF-A and CA9.VEGF-A 和 CA9 中与氧无关的二硫键形成。
Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production.
替加环素拮抗硼替佐米对骨髓瘤细胞的作用,减少线粒体活性氧的产生。
Int J Mol Sci. 2024 Apr 30;25(9):4887. doi: 10.3390/ijms25094887.
4
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives.探索组蛋白去乙酰化酶及组蛋白去乙酰化酶抑制剂在多发性骨髓瘤中的作用:作用机制、治疗意义及未来展望
Exp Hematol Oncol. 2024 Apr 23;13(1):45. doi: 10.1186/s40164-024-00507-5.
5
Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma.达雷妥尤单抗治疗多发性骨髓瘤疗效与安全性的荟萃分析。
World J Clin Cases. 2023 Oct 16;11(29):7091-7100. doi: 10.12998/wjcc.v11.i29.7091.
6
Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma.自噬:一种应对多发性骨髓瘤药物耐药性的潜在治疗靶点。
Int J Mol Sci. 2023 Mar 23;24(7):6019. doi: 10.3390/ijms24076019.
J Biol Chem. 2021 Jan-Jun;296:100505. doi: 10.1016/j.jbc.2021.100505. Epub 2021 Mar 3.
4
Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels.新诊断多发性骨髓瘤患者的细胞因子谱:生存与 IL-6 和 IL-17A 水平相关。
Cytokine. 2021 Feb;138:155358. doi: 10.1016/j.cyto.2020.155358. Epub 2020 Nov 10.
5
BCMA-targeted immunotherapy for multiple myeloma.BCMA 靶向免疫疗法治疗多发性骨髓瘤。
J Hematol Oncol. 2020 Sep 17;13(1):125. doi: 10.1186/s13045-020-00962-7.
6
The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB.未折叠蛋白反应通过 sXBP1 介导的 TFEB 激活调节肝自噬。
Autophagy. 2021 Aug;17(8):1841-1855. doi: 10.1080/15548627.2020.1788889. Epub 2020 Jul 15.
7
The NF-KB pathway and endocrine therapy resistance in breast cancer.NF-KB 通路与乳腺癌内分泌治疗抵抗。
Endocr Relat Cancer. 2019 May 9;26(6):R369-R380. doi: 10.1530/ERC-19-0087.
8
UPR proteins IRE1 and PERK switch BiP from chaperone to ER stress sensor.未折叠蛋白反应(UPR)途径中的IRE1 和 PERK 蛋白将结合蛋白(BiP)从伴侣蛋白转换为内质网应激传感器。
Nat Struct Mol Biol. 2019 Nov;26(11):1053-1062. doi: 10.1038/s41594-019-0324-9. Epub 2019 Nov 6.
9
The Maintenance of Memory Plasma Cells.记忆浆细胞的维持。
Front Immunol. 2019 Apr 5;10:721. doi: 10.3389/fimmu.2019.00721. eCollection 2019.
10
The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer.自噬对癌症相关成纤维细胞在癌症中的作用和机制。
J Exp Clin Cancer Res. 2019 Apr 23;38(1):171. doi: 10.1186/s13046-019-1172-5.